NDC 0299-6220 – Nemluvio

Nemolizumab 30 mg/100mg · Injection, Powder, Lyophilized, For Solution · Subcutaneous

Human Prescription Drug

Product NDC0299-6220

Product details

Brand name
Nemluvio
Generic name
Nemolizumab-ilto
Labeler
Galderma Laboratories, L.P.
Dosage form
Injection, Powder, Lyophilized, For Solution
Route
Subcutaneous
Marketing category
BLA · BLA761390
Marketed since
August 13, 2024
Listing expires
December 31, 2026
Pharmacologic class
Interleukin-31 Receptor alpha Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Nemluvio →

Package NDC codes (2)

Package NDCDescriptionSince
0299-6220-10 sample1 SYRINGE, GLASS in 1 CARTON (0299-6220-10) / 30 mg in 1 SYRINGE, GLASSAug 13, 2024
0299-6220-151 SYRINGE in 1 CARTON (0299-6220-15) / 30 mg in 1 SYRINGEAug 13, 2024